Catherine Becht

596 total citations
9 papers, 123 citations indexed

About

Catherine Becht is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine Becht has authored 9 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine Becht's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Catherine Becht is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Catherine Becht collaborates with scholars based in France and Netherlands. Catherine Becht's co-authors include Marc Ychou, Damien Pouessel, Didier Cupissol, Gilles Romieu, Michel Fabbro, Frédéric Pinguet, Stéphane Culine, Stéphane Culine, Simon Thézenas and Pierre Sénesse and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancers.

In The Last Decade

Catherine Becht

9 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Becht France 6 84 49 47 32 27 9 123
Alicia‐Marie Conway United Kingdom 6 85 1.0× 50 1.0× 37 0.8× 19 0.6× 40 1.5× 13 129
Fred Kirsten Australia 5 77 0.9× 50 1.0× 29 0.6× 21 0.7× 9 0.3× 8 149
Emilie Sohier France 5 54 0.6× 61 1.2× 8 0.2× 16 0.5× 30 1.1× 7 128
Michiel de Maaker Netherlands 7 62 0.7× 22 0.4× 24 0.5× 18 0.6× 71 2.6× 9 176
Eran Goren Israel 4 54 0.6× 42 0.9× 31 0.7× 71 2.2× 101 3.7× 5 197
Marianna Sampaio Serpa Brazil 7 55 0.7× 42 0.9× 50 1.1× 7 0.2× 9 0.3× 14 124
Shigemi Ito Japan 7 73 0.9× 16 0.3× 20 0.4× 27 0.8× 13 0.5× 13 135
Irene Guijarro United States 2 112 1.3× 41 0.8× 47 1.0× 19 0.6× 21 0.8× 6 197
Emilio Fonseca‐Sánchez Spain 6 45 0.5× 8 0.2× 14 0.3× 25 0.8× 12 0.4× 18 106
Ken-Wing Lee United States 2 100 1.2× 45 0.9× 20 0.4× 12 0.4× 6 0.2× 2 142

Countries citing papers authored by Catherine Becht

Since Specialization
Citations

This map shows the geographic impact of Catherine Becht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Becht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Becht more than expected).

Fields of papers citing papers by Catherine Becht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Becht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Becht. The network helps show where Catherine Becht may publish in the future.

Co-authorship network of co-authors of Catherine Becht

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Becht. A scholar is included among the top collaborators of Catherine Becht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Becht. Catherine Becht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lamy, Pierre‐Jean, Paul van der Leest, Catherine Becht, et al.. (2020). Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study. Cancers. 12(10). 3002–3002. 23 indexed citations
2.
Pouessel, Damien, Hélèna Huguet, F. Iborra, et al.. (2010). A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.. PubMed. 30(11). 4711–5. 5 indexed citations
3.
Trédaniel, Jean, Catherine Becht, Hubert de Crémoux, et al.. (2008). An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients. Lung Cancer. 63(2). 259–263. 4 indexed citations
4.
5.
Trédaniel, Jean, Catherine Becht, Stéphane Culine, et al.. (2006). A multicentric phase II trial of gemcitabine (Gem), oxaliplatin (Oxa) and vinorelbine (VNB) in untreated stage IIIB and IV non-small cell lung cancer (NSCLC) patients (pts): Preliminary results of GON triplet regimen. Journal of Clinical Oncology. 24(18_suppl). 17104–17104. 1 indexed citations
6.
Thézenas, Simon, et al.. (2005). Hepatic metastases from carcinomas of unknown primary site. Gastroentérologie Clinique et Biologique. 29(12). 1224–1232. 26 indexed citations
7.
Pouessel, Damien, Stéphane Culine, Catherine Becht, et al.. (2004). Gemcitabine and docetaxel as front‐line chemotherapy in patients with carcinoma of an unknown primary site. Cancer. 100(6). 1257–1261. 36 indexed citations
8.
Culine, Stéphane, Gilles Romieu, Michel Fabbro, et al.. (2004). Reducing the time interval between cycles using standard doses of docetaxel and lenogastrim support. Cancer. 101(1). 178–182. 4 indexed citations
9.
Pouessel, Damien, Stéphane Culine, Catherine Becht, et al.. (2003). Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.. PubMed. 23(3C). 2801–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026